Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1979 Apr;38(2):148–151. doi: 10.1136/ard.38.2.148

Diflunisal in osteoarthrosis of the hip and knee.

W K Essigman, M A Chamberlain, V Wright
PMCID: PMC1000340  PMID: 375849

Abstract

Diflunisal (750 mg per day) has been compared with acetylsalicylic acid (ASA) (3000 mg per day) in the treatment of osteoarthrosis of the hip and knee in a double-blind, randomised, multicentre, outpatient study. Thirty-one patients entered the diflunisal group and 29 the ASA group. The response of the 2 groups was comparable, but the incidence of side effects was higher in the ASA group. At the end of the 12-week period more patients in the diflunisal group chose to remain in a further, open study.

Full text

PDF
148

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Majerus P. W., Stanford N. Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles. Br J Clin Pharmacol. 1977 Feb;4 (Suppl 1):15S–18S. doi: 10.1111/j.1365-2125.1977.tb04509.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Stone C. A., Van Arman C. G., Lotti V. J., Minsker D. H., Risley E. A., Bagdon W. J., Bokelman D. L., Jensen R. D., Mendlowski B., Tate C. L. Pharmacology and toxicology of diflunisal. Br J Clin Pharmacol. 1977 Feb;4 (Suppl 1):19S–29S. doi: 10.1111/j.1365-2125.1977.tb04510.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Van Winzum C., Rodda B. Diflunisal: efficacy in postoperative pain. Br J Clin Pharmacol. 1977 Feb;4 (Suppl 1):39S–43S. doi: 10.1111/j.1365-2125.1977.tb04513.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Wright V., Hopkins R. Administration of antirheumatic drugs. Ann Rheum Dis. 1976 Apr;35(2):174–176. doi: 10.1136/ard.35.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES